About Q&Q Labs
Q&Q Labs is a company based in Molndal (Sweden) founded in 2010 was acquired by Scantox in August 2023. Q&Q Labs offers products and services including Discovery Services, Genetic Toxicology, Regulatory Toxicology, and Pharmaceutical Development. Q&Q Labs operates in a competitive market with competitors including Gentronix, Tigermed, Shanghai Yaocheng Health Technology, ReveraGen and Aquila BioMedical, among others.
- Headquarter Molndal, Sweden
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Scantox Holding Aps
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Q&Q Labs
Q&Q Labs offers a comprehensive portfolio of products and services, including Discovery Services, Genetic Toxicology, Regulatory Toxicology, and Pharmaceutical Development.
Specialized services for neurology drug discovery and efficacy testing.
Assessment of genotoxicity for drug safety evaluation.
GLP-compliant studies using animal models for regulatory compliance.
Formulation and bioanalysis for drug development processes.
Funding Insights of Q&Q Labs
Detailed funding history for QQ Labs
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Q&Q Labs
Q&Q Labs has secured backing from 1 investor. Prominent investors backing the company include Scantox.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Laboratory focused on providing pharmacology, toxicology, and histopathology services
|
Locked | Locked | Locked |
Investor details for QQ Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Q&Q Labs
Investment portfolio details for QQ Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - QQ Labs
Detailed financials for QQ Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Q&Q Labs Comparisons
Peer comparison for QQ Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Q&Q Labs
Q&Q Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gentronix, Tigermed, Shanghai Yaocheng Health Technology, ReveraGen and Aquila BioMedical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
In-vitro and in-vivo genetic toxicology screening services are provided.
|
|
| Locked | Locked | Locked |
Drug development and preclinical services are provided by Tigermed.
|
|
| Locked | Locked | Locked |
Clinical trial services to biopharma sector are provided.
|
|
| Locked | Locked | Locked |
Steroids for Duchenne muscular dystrophy treatment are developed.
|
|
| Locked | Locked | Locked |
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
|
|
| Locked | Locked | Locked |
Contract research on infectious disease models is conducted.
|
Detailed competitors of QQ Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Q&Q Labs
Complete news archive for QQ Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Q&Q Labs
Q&Q Labs was founded in 2010.
Q&Q Labs is headquartered in Molndal, Sweden. It is registered at Molndal, Vastra Gotaland, Sweden.
QQ Labs was founded in 2010 and is based in Molndal, Sweden. Preclinical research is conducted with a focus on pharmacology and toxicology services for the pharmaceutical, biotechnology, and medical devices industries. Identification and quantification processes are handled reliably across multiple applications, supporting development needs in these sectors. Operations emphasize standard protocols for safety and efficacy assessments.
Q&Q Labs offers Discovery Services, Genetic Toxicology, Regulatory Toxicology, and Pharmaceutical Development.
Q&Q Labs has 1 investor. Key investors include Scantox.